baber/WOPTO huggingface dataset:
Patent ES-2041233-T1 (ES)
IPC: E05D15/06
Filed: 1992-09-23
Abstract: A panel, such as a door or wall partition, with a unit for swinging and sliding the panel. Particularly, a fixing and locking unit which is located in a housing, and can be retrofitted on all existing door systems. By means of a fixing screw and a locking screw which can be operated from the floor by means of a tool, the door can either be released or blocked in its sliding or its swinging direction.
Patent ES-2118685-T1 (ES)
Inventor: HUBER EDGAR
IPC: A47B88/00
Filed: 1996-10-11
Abstract: PCT No. PCT/AT96/00195 Sec. 371 Date Jun. 30, 1997 Sec. 102(e) Date Jun. 30, 1997 PCT Filed Oct. 11, 1996 PCT Pub. No. WO97/16090 PCT Pub. Date May 9, 1997A device for fastening a front plate of a drawer to a drawer side wall includes a flange, at least one expandable dowel to be inserted into a hole in the front plate, the dowel being separate from and not integral with the flange, and an expanding member positioned within the dowel and movable therein between an expanding position and a release position, the expanding member having an end extending from the dowel. The dowel and the expanding member are positioned on a first side of the flange to face the front plate, with the end of the expanding member passing through an aperture in the flange. A tensioning lever is positioned at a second side of the flange directed away from the front plate and is pivotally connected to the end of the expanding member for pivoting movement between a released position and a tensioning position. The tensioning lever has a cam operable to act on the flange when the tensioning lever is pivoted to the tensioning position, thus to pull the expanding member relative to the dowel to expand the dowel outwardly and to clamp the flange between the dowel and the cam.
Patent CY-1106977-T1 (CY)
Inventor: SCHULZ HANS-HERRMANN
IPC: A61P31/04
Filed: 2007-11-06
Abstract: The use of active agent(s) (A) selected from 4-oxo-quinoline-3-carboxylic acid derivatives (including naphthyridine or quinolizine analogs) (I) or (II) for topical and/or local treatment or prophylaxis of bacterial diseases in humans or animals is new.  The use of one or more active agent(s) (A) selected from 4-oxo-quinoline-3-carboxylic acid derivatives (including naphthyridine or quinolizine analogs) of formula (I) or (II) and their hydrates, acid addition salts, carboxylate salts, enantiomers, diastereomers, racemates or mixtures, optionally together with auxiliaries, is claimed for the preparation of medicaments for topical and/or local treatment or prophylaxis of bacterial diseases in humans or animals. The use of ciprofloxacin for the treatment of eye or ear diseases is excluded.  A  =  CH, C(halogen), C(Me), C(CN), C(OMe), C(OCHF2) or N;  R1  =  1-5C alkyl, 2-5C alkenyl, 2-fluoroethyl, cycloalkyl, bicycloalkyl, 2-fluorocyclopropyl, 1-oxetan-3-yl, NHMe, optionally substituted phenyl or pyridyl;  or A + R1  =  C-O-CH2-CH(Me)-;  R2  =  H or 1-3C alkyl (optionally substituted by OH, halo or NH2);  R3  =  H, halo, Me, NH2 or NHNH2;  R4  =  H, halo or NH2;  R5, R'2  =  optionally substituted mono-, bi- or tricyclic alicyclic system (optionally containing double bond(s)) or mono-, bi- or tricyclic aromatic system (both optionally containing heteroatom(s));  R'1  =  H or 1-3C alkyl. An Independent claim is included for gel formulations containing one or more (A).
Patent CY-1110013-T1 (CY)
Inventor: ZELDIS JEROME B
IPC: A61K31/4035
Filed: 2010-04-23
Abstract: Methods of treating, preventing and/or managing cancer as well as diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Patent CY-1111048-T1 (CY)
Title: Ενωσεις που εμφανιζουν αντικαρκινικη δραστηριοτητα
Inventor: PELUSO GIANFRANCO
IPC: A61P35/00
Filed: 2010-11-03
Abstract: Αποκαλύπτεται η χρήση ενώσεων του χημικού τύπου (I), όπου τα Χ, Υ και Ζ είναι όπως ορίζονται στην περιγραφή της εφεύρεσης, για την παρασκευή αντικαρκινικού φαρμάκου, προαιρετικά σε συνδυασμό με κατά διαφορετικό τρόπο βιολογικά ενεργές ουσίες.
Patent CY-1110940-T1 (CY)
Inventor: PEPPMÖLLER REINMAR
IPC: C05G3/80
Filed: 2010-11-24
Abstract: The invention is directed to a crumbly, water-absorbing, soil-like hydrogel. The hydrogel comprises finely comminuted mineral substances, such as igneous rock; water-soluble alkali-silicate; solid and liquid nutrient additives; and ballast, bound in a cross-linked polymer. The hydrogel is structured like a sponge and absorbs water and liquids when in contact with water or aqueous liquids. The mineral substances present in the hydrogel may be present in an amount of at least 30% by weight of the dried hydrogel. Also, the invention encompasses methods of producing acidic and neutral to weakly alkaline hydrogels.
Patent CY-1112602-T1 (CY)
Title: Κρυσταλλικη τροποποιηση fipronil
Inventor: SAXELL HEIDI EMILIA
IPC: A01P7/00
Filed: 2011-08-30
Abstract: Η παρούσα εφεύρεση αφορά σε μια κρυσταλλική τροποποίηση του fipronil, σε μια διαδικασία για την παρασκευή της ίδιας, ζιζανιοκτόνα και παρασιτοκτόνα μείγματα και συνθέσεις που περιλαμβάνουν την εν λόγω κρυσταλλική τροποποίηση και την χρήση τους για την καταπολέμηση ζιζανίων και παρασίτων.
Patent CY-1112913-T1 (CY)
Inventor: PUETZ NORBERT
IPC: H01L31/0256
Filed: 2012-05-21
Abstract: An opto-electronic device, such as a solar cell or a light emitting diode, is fabricated by forming a nucleating layer (22) on a p-type group IV layer (20). The nucleating layer (22) includes a III-V compound selected from the group consisting of AlAs, AlSb, AIN, Bas, BSb, GaN, GaSB, and InAs. A first III-V compound layer (24) is formed on the nucleating layer (22) and includes as group III element, at least one of gallium, indium, and aluminium, and as a group V element, phosphorus. The p-type group IV layer, which may be a p-type silicon layer, includes phosphorus atoms diffused from the first III-V compound layer, the concentration of the phosphorus atoms therein being a function of the thickness of the nucleating layer. The first III-V compound layer includes group IV atoms diffused from the p-type group IV layer, the concentration of the group IV atoms therein being a function of the thickness of the nucleating layer.
Patent CY-1117720-T1 (CY)
Title: Οπτοηλεκτρονικη συσκευη και μεθοδος κατασκευης αυτης
Inventor: TOPPING ALEXANDER JOHN
IPC: H01L31/18
Filed: 2016-07-05
Abstract: Μια οπτοηλεκτρονική συσκευή περιλαμβάνει ένα υπόστρωμα που έχει μια πρώτη και μια δεύτερη σειρά από αύλακες και ένα κανάλι ανάμεσα τους. Καθεμία αύλακας της πρώτης και της δεύτερης σειράς αυλακών έχει μια πρώτη και μια δεύτερη φάση και μια κοιλότητα ανάμεσα. Η κοιλότητα γεμίζεται τουλάχιστον μερικώς με ένα πρώτο ημιαγώγιμο υλικό. Η πρώτη φάση επιστρώνεται με ένα αγώγιμο υλικό και η δεύτερη φάση επιστρώνεται με ένα δεύτερο ημιαγώγιμο υλικό. Το κανάλι διασχίζει τις αύλακες της πρώτης και της δεύτερης σειράς αυλακών. Επίσης, μια μέθοδο παραγωγής μιας οπτοηλεκτρονικής συσκευή.
Patent CY-1120123-T1 (CY)
Title: Μονοκλωνικα αντισωματα κατα της gt468 για τη θεραπεια του καρκινου
Inventor: SAHIN UGUR
IPC: C07K16/30
Filed: 2018-04-11
Abstract: Η παρούσα εφεύρεση παρέχει αντισώματα χρήσιμα ως θεραπευτική αγωγή για τη θεραπεία και/ ή την πρόληψη νόσων που σχετίζονται με κύτταρα τα οποία εκφράζουν το GT468, περιλαμβανομένων νόσων που σχετίζονται με τον καρκίνο, όπως είναι ο καρκίνος του μαστού, ο καρκίνος των πνευμόνων, ο γαστρικός καρκίνος, ο καρκίνος των ωοθηκών, και ο ηπατοκυτταρικός καρκίνος.
Patent CY-1122784-T1 (CY)
Title: Αλογονωμενες κιναζολιν-τηf-αμινες ως αναστολεις του ρdε1
Inventor: KEHLER JAN
IPC: C07D403/12
Filed: 2020-03-04
Abstract: Η παρούσα εφεύρεση παρέχει αλογονωμένες κιναζολιν-ΤΗF-αμίνες ως αναστολείς του ΡDΕ1 και τη χρήση τους ως φάρμακο, συγκεκριμένα για τη θεραπεία νευροεκφυλιστικών διαταραχών και ψυχιατρικών διαταραχών.
Patent HR-P20100265-T1 (HR)
Title: Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
Inventor: ALLAND LEILA
IPC: A61K31/506
Filed: 2010-05-12
Abstract: The invention provides a pharmaceutical combination comprising: a) a pyrimidylaminobenzamide compound, and b) imatinib. and a method for treating or preventing a proliferative disease, especially GIST, using such a combination.
Patent HR-P20110261-T1 (HR)
Inventor: MULLER GEORGE W
IPC: A61P35/00
Filed: 2011-04-12
Abstract: Spoj sa strukturom formule (II): ili njegova farmaceutski prihvatljiva sol, solvat ili stereoizomer, naznačen time što: * označuje kiralni centar; X je CH2 ili C=O; R je (C1-C6)alkil; (C1-C6)alkoksi; amino; (C1-C6)alkil-amino; dialkilamino, gdje svaka od alkilnih skupina je neovisno (C1-C6)alkil; (C0-C4)alkil-(C6-C10)aril, izborno supstituiran s jednim ili više (C1-C6)alkila, (C1-C6)alkoksi ili halogena; 5- do 10-eročlani heteroaril, izborno supstituiran s jednim ili više (C1-C6)alkila; -NHR'; ili (C0-C8)alkil-N(R'')2;R' je: (C1-C6)alkil; (C0-C4)alkil-(C6-C10)aril, izborno supstituiran s jednim ili više: (C1-C6)alkila, gdje je navedeni alkil sam izborno supstituiran s jednim ili više halogena, (C1-C6)alkoksi, gdje je navedeni alkoksi sam izborno supstituiran s jednim ili više halogena, (C1-C6)alkilendioksi, ilihalogen; ili5- do 10-eročlani heteroaril, izborno supstituiran s jednim ili više (C1-C6)alkila; iR'' je svaki put neovisno H, (C1-C8)alkil, (C2-C8)alkenil, (C2-C8)alkinil, benzil, (C6-C10)aril, 5- do 10-eročlani heteroaril ili (C0-C8)alkil-C(O)O-(C1-C8)alkil. Patent sadrži još 13 patentnih zahtjeva.
Patent HR-P20110815-T1 (HR)
Title: Rail steel with an excellent combination of wear properties and rolling contact fatigue resistance
Inventor: CARROLL ROBERT
IPC: E01B5/02
Filed: 2011-11-02
Abstract: A high-strength pearlitic steel rail with an excellent combination of wear properties and rolling contact fatigue resistance wherein the steel has 0.88% to 0.95% carbon, 0.75% to 0.92% silicon, 0.80% to 0.95% manganese, 0.05% to 0.14% vanadium, up to 0.008% nitrogen, up to 0.030% phosphorus, 0.008 to 0.030% sulphur, at most 2.5 ppm hydrogen, at most 0.10% chromium, at most 0.010% aluminium, at most 20 ppm oxygen, the remainder being iron and unavoidable impurities.
Patent SI-1190135-T1 (SI)
Title: Front-loading washing machine comprising a rotatable laundry basket
Inventor: USZKUREIT DETLEF
IPC: D06F23/06
Filed: 2000-05-31
Abstract: A front-loading washing machine includes a rotatable laundry basket. The basket's lowest casing line deviates from horizontal by sloping upward toward the front when the machine is in an operating position. The basket has hollow longitudinally extended carriers disposed on the inside surface of the casing and including liquid inlets in the basket's rear area. The inlets are loaded with liquid when the basket rotates into a lowest position and direct the liquid into the carriers, which lift the liquid therein and deliver it from a lifted position into the basket's interior through openings. The basket remains easy to manufacture while ensures both rapid wetting of the laundry and at least equally good washing action. The laundry basket is mounted cylindrically around a rotational axis that slopes upward toward the front, and the carriers are slantingly disposed with regard to the basket rotation direction.
Patent SI-1318000-T1 (SI)
Title: Binder for manufacturing and binding of wood and timber products
Inventor: KRUG DETLEF
IPC: C08L61/14
Filed: 2002-12-04
Abstract: Binder for the production of swelling-compensated wood materials and for bonding wood and wood materials consists of a phenol-formaldehyde resin component (I) and a natural component (II) containing low-molecular wheat and/or maize protein. (I) is a modified resin with pH 7-13 and (II) is added and/or condensed with this during resin production.
Patent SI-1980252-T1 (SI)
Title: Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Inventor: YAKATAN GERALD
IPC: A61P21/00
Filed: 2003-07-17
Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
Patent SI-1612160-T1 (SI)
Title: Dispensing and disposal container for hygiene items
Inventor: WEINMANN GEROLD DR
IPC: A61F15/00
Filed: 2005-04-15
Abstract: The receptacle has a hold space (3) for the article and a storage space (4) for the packings i.e. plastic bags (14) which takes up the article for disposal. The dump opening (6) at the front side of receptacle allows the articles to be thrown into hold space, and withdrawal opening (13) allows the packings to be taken out.
Patent SI-1968756-T1 (SI)
Title: Method for obtaining a bio-stabilised woodland substrate from the integral cycle of urban solid waste treatment
Inventor: CERRONI MANLIO
IPC: B09B3/00
Filed: 2006-12-08
Abstract: A method for obtaining a woodland substrate from the complete recycling of the materials recovered from treatment of urban solid waste is disclosed. The woodland substrate obtained by the process is also described.
Patent SI-1964621-T1 (SI)
Title: Device and method for manufacturing profiles
Inventor: ENOCKL WALTER
IPC: B21D5/00
Filed: 2008-02-19
Abstract: The method involves rolling a surface finished sheet metal strip (1) applied with protection layer (2). The protection layer, arranged on the metal strip, is partly cut in the predetermined areas. The cutting of the protection layer is carried out with a cutting line, which moves perpendicularly on the surface of the metal strip. The cutting line runs partly inclined to a transport device of the metal strip. The metal strip is rolled to a profile strand. An independent claim is also included for a profile system with a line arranged roll pair.
Patent SI-2215058-T1 (SI)
Title: Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
Inventor: CZECHTIZKY WERNGARD
IPC: A61K31/00
Filed: 2008-10-14
Abstract: The present invention discloses and claims a series of substituted N-phenyl-bipyrrolidine ureas of formula (I). Wherein R, R1, R2, R3, R4 and R5 are as described herein. More specifically, the compounds of this invention are modulators of H3 receptors and are, therefore, useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases modulated by H3 receptors including diseases associated with the central nervous system. Additionally, this invention also discloses methods of preparation of substituted N-phenyl-bipyrrolidine ureas and intermediates therefor.
Patent TR-200401036-T1 (TR)
Inventor: GABOR PAL S
IPC: A61K/
Filed: 2003-03-13
Abstract: The invention relates to the use of citalopram or a pharmaceutically acceptable salt thereof for the preparation of pharmaceutical compositions suitable for the treatment of elevated (high) blood pressure, normalization of blood pressure or the decrease of elevated blood pressure and/or prevention of elevated blood pressure.
Patent TR-200906465-T1 (TR)
Inventor: TAUBER MICHAEL
IPC: A61F2/44
Filed: 2007-08-23
Abstract: An intervertebral implant has an implant structure providing a fixation surface for fixation to the endplate of a vertebral body. The fixation surface includes two bone contact regions at different heights in an axial direction. A transition between the two contact regions has a stepped form including at least two steps.
Patent DE-3687241-T2 (DE)
Inventor: IWATA KENNETH K
IPC: A61P43/00
Filed: 1986-04-15
Granted: 1993-07-01
Abstract: An acidified, ethanol extract derived from human tissue which comprises a plurality of acidic polypeptides, each of which has a molecular weight less than about 20,000 daltons and each of which has the property of inhibiting the growth of human tumor cells and of an established mink lung cell line (CCL64) while stimulating the growth of normal human foreskin fibroblasts is disclosed. The inhibitory activity against human tumor cell growth is not destroyed upon increasing the temperature of the acidified, ethanol extract to about 100 DEG C for about 3 minutes or adding acetic acid until the acidified, ethanol extract is up to about 1.0 molar in acetic acid. Further, the activity of the acidified, ethanol extract is enhanced when the acidified, ethanol extract is prepared at about 4 DEG C rather than about at 23 DEG C. An acidified, ethanol extract derived from human umbilical cord which has been treated to re   moved substantially all blood, all extracellular soluble components and substantially all intracellular soluble components which comprises at least one acidic polypeptide having an apparent molecular weight less than about 30,000 daltons, compositions of matter designated tissue-derived growth inhibitor-1 (TGI-1), tissue-derived growth inhibitor (TGI), and tissue-derived growth inhibitor-2 (TGI-2) and a heterogeneous population of polypeptides designated CM-I, CM-II, CM-III and CM-IV, are also disclosed as are methods of preparation, pharmaceutical compositions which include, and uses of the foregoing.
Patent DE-3688293-T2 (DE)
Inventor: KOTA TOSHIO
IPC: B41F23/08
Filed: 1986-10-14
Granted: 1993-07-29
Abstract: A varnishing apparatus for a printed sheet includes: a metering roller (33), to a peripheral surface of which a varnish from a varnish duct (27) is transferred; a form roller (43) which is brought into contact with a downstream side of the metering roller (33), and is rotated in the same direction as that of the metering roller (33) to allow transfer of the varnish from the metering roller (33); and a rubber blanket cylinder (23) which is brought into contact with a downstream side of the form roller (43) and is rotated in a direction opposite to that of the form roller (43) to allow transfer of the varnish from the form roller (43), the rubber blanket cylinder having a notch on its outer peripheral portion and transferring the varnish onto a sheet which is in contact with its peripheral surface. The surface (33a) of the metering roller is formed of an elastic material having a roughened surface.
Patent DE-3783642-T2 (DE)
Inventor: SIMMS JOHN ALVIN
IPC: C08L53/00
Filed: 1987-04-16
Granted: 1993-06-03
Abstract: A blend of a softer continuous phase polymer reinforced with harder acrylic star polymer particles having reactive functional groups with crosslinking ability built in or provided by a third polymer. The harder polymer has a Tg at least 10 DEG C above that of the softer polymer, and the acrylic star polymer is preferably made by group transfer polymerization. This blend provides coating compositions, films and bulk polymer with enhanced toughness and flexibility.
Patent DE-3784127-T2 (DE)
Inventor: HAUCK BOBBIE W
IPC: B01F7/04
Filed: 1987-10-08
Granted: 1993-06-03
Abstract: A conditioning device for an extruder (14) includes two juxtaposed, frustocylindrical, intercommunicated chambers (24-26), one chamber of which has a greater cross sectional area than the other chamber. A mixing shaft (28) centrally located within the small chamber carries a number of radially extending beaters which rotate at a speed twice that of the rotational speed of paddles mounted on a second mixing shaft (36) located in the large chamber and material introduced into the vessel is passed from side-to-side between the two chambers while being advanced along the length of the vessel. The use of relatively fast moving beaters within a small mixing chamber in combination with relatively slow moving paddles in a larger mixing chamber enables flour-like materials to be properly blended with water with both sufficient agitation and proper retention times within the vessel. In an alternate embodiment of the invention, the vessel is tiltable about an axis parallel to the longitudinal axis thereof, in order to bias the materials under the influence of gravity toward one chamber or the other and to thereby vary the residence time of the materials within the vessel and the mixing characteristics of the device.
Patent DE-3874352-T2 (DE)
Inventor: ZAPPIA VINCENZO
IPC: C12P19/40
Filed: 1988-10-05
Granted: 1992-12-17
Abstract: Liposoluble salts of S-adenosyl-L-methionine (SAM) with acyl derivatives of taurine having the formula: SAMn[R-CO-NH-(CH2)2-SO-3]n in which R-CO is a member selected from C12-C26 saturated and unsaturated, linear and branched acyl, and C2-C26 cycloalkyl-substituted acyl, and n is from 3 to 6 according to the SAM charge, and pharmaceutical compositions containing the salts.
Patent DE-3883943-T2 (DE)
Inventor: WERQUIN JEAN-CLAUDE
IPC: C22C38/40
Filed: 1988-12-19
Granted: 1994-03-24
Abstract: A bimetallic composite back-up cylinder for a rolling mill, in particular for a four-coil or six-roll stand of a hot strip train finisher, comprises a metal envelope made of a steel having a chromium content between 13 and 17 wt. %, and a carbon content between 0.5 and 0.8 wt. % the chromium/carbon ratio being between 20 and 25.
Patent TR-199801398-T2 (TR)
Inventor: UCHIDA YOSHIYUKI
IPC: A61K31/195
Filed: 1997-01-27
Abstract: The description relates to a therapeutic agent which comprises as the active agent a compound given by the formula (1) and/or (1') and/or a pharmaceutically acceptable salt thereof. The agent of the invention exhibits great effectiveness in cases of both immediate and later asthmatic reactions, especially the latter. Owing to its low toxicity, the agent of the invention can safely be prescribed for human beings.
Patent TR-199802150-T2 (TR)
Inventor: VOLKERT OTTO
IPC: C08G101/00
Filed: 1997-04-24
Abstract: Elastic polyurethane moldings having a compact surface and a cellular core are produced by reactinga) modified organic polyisocyanates withb) at least one relatively high molecular weight compound containing at least two reactive hydrogen atoms and, if desired,c) low molecular weight chain extenders in the presence ofd) blowing agents,e) catalysts and, if desired,f) customary auxiliaries and/or additivesin a closed mold with compaction, wherein the modified organic polyisocyanate used is at least one reaction product of pure MDI and at least one polyether alcohol (polyoxyalkylene polyol), the modified organic polyisocyanate having an NCO content of <15% by weight.
Patent TR-199802331-T2 (TR)
Inventor: GUERRY PHILIPPE
IPC: A61K31/505
Filed: 1997-05-07
Abstract: Mevcut bulus, içerisindeki R1'in alt-alkoksiyi, R2'nin bromini, alt-alkoksiyi veya hidroksiyi, R3'ün hidrojeni, alt-alkili, sikloalkili, arili, heteroarili, aralkili, heteroaralkili veya siyanoyu, R4 ve R5'in birbirlerinden bagimsiz olarak hidrojeni, alt-alkili, alt-alkoksiyi, halojeni, hidroksiyi, aminoyu, di(alt alkil)-aminoyu, siyanoyu veya nitroyu ve Q'nun da etinilen veya vinileni isaret ettigi genel formül (I)'deki bilesenler ve bu bilesenlerin tuzlarinin farmasötik açidan kullanimlari, bu bilesenlerin ve tuzlarinin tedavi açisindan aktif maddeler olarak kullanimlari; bu maddelere ve bunlarin üretimine bagli ilaçlar; bu maddelerin ilaç olarak ve antibakteriyel açidan aktif olan ilaçlarin üretimi için kullanilmalari ile ilgilidir.
Patent DE-60000531-T2 (DE)
Inventor: HARROP MARTIN
IPC: G10K11/02
Filed: 2000-09-22
Granted: 2003-06-26
Abstract: An ultrasonic cutting system comprising an ultrasonic vibrating device having an operative face, a block horn having a responsive face connected to the operative face of the ultrasonic vibrating device and an operative face and being provided with at least one normal tuning slot having a width of from 4 to 6mm traversing the block between its operative and responsive faces, a plurality of cutting blades mounted on the operative face of the block horn so as to be vibrated thereby/therewith, the blades lying in a plane containing the longitudinal axis of vibrations characterised in that the block horn is also provided with at least one thin tuning and damping slot having a width of from 0.1 to 2.5mm traversing the block horn between its operative and responsive faces. <IMAGE>